Drug major Jubilant Life
Sciences has received a nod from the US Food and Drugs Administration (FDA) to
market a generic diuretic medicine, the company said on Friday.The
Spironolactone tablets (25 mg, 50 mg and 100 mg), which received the
abbreviated new drug application approval, is the generic version of GD
Searle’s Aldactone. It is used to treat fluid retention in the body caused by
conditions such as congestive heart failure and cirrhosis of the liver.Jubilant
said it will launch this product, which has a market size of $87 million a
year, in the first quarter of the fiscal year 2015-16.
Indian Biological Sciences and Research Institute, located in NCR, Noida and it is QCI(Quality Council Of India body of Government of India) an ISO 9001-2008 certified institute and it is and unit of Exordior Technical Services Private Limited.IBRI is an institute of its own kind as it is governed and managed by academician and professionals from different fields i.e Bioinformatics, Biotechnology, Pharmacy, IT, Clinical Trials etc. forming the backbone of the institute for its success.
No comments:
Post a Comment